ICD 9 Range DRUGS, MEDICINAL AND BIOLOGICAL SUBSTANCES CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

• 1  Antibiotics causing adverse effects in therapeutic use     ( E930 )

• 2  Penicillins causing adverse effects in therapeutic use     ( E930.0 )

• 3  Antifungal antibiotics causing adverse effects in therapeutic use     ( E930.1 )

• 4  Chloramphenicol group causing adverse effects in therapeutic use     ( E930.2 )

• 5  Erythromycin and other macrolides causing adverse effects in therapeutic use     ( E930.3 )

• 6  Tetracycline group causing adverse effects in therapeutic use     ( E930.4 )

• 7  Cephalosporin group causing adverse effects in therapeutic use     ( E930.5 )

• 8  Antimycobacterial antibiotics causing adverse effects in therapeutic use     ( E930.6 )

• 9  Antineoplastic antibiotics causing adverse effects in therapeutic use     ( E930.7 )

• 10  Other specified antibiotics causing adverse effects in therapeutic use     ( E930.8 )

• 11  Unspecified antibiotic causing adverse effects in therapeutic use     ( E930.9 )

• 12  Other anti-infectives causing adverse effects in therapeutic use     ( E931 )

• 13  Sulfonamides causing adverse effects in therapeutic use     ( E931.0 )

• 14  Arsenical anti-infectives causing adverse effects in therapeutic use     ( E931.1 )

• 15  Heavy metal anti-infectives causing adverse effects in therapeutic use     ( E931.2 )

• 16  Quinoline and hydroxyquinoline derivatives causing adverse effects in therapeutic use     ( E931.3 )

• 17  Antimalarials and drugs acting on other blood protozoa causing adverse effects in therapeutic use     ( E931.4 )

• 18  Other antiprotozoal drugs causing adverse effects in therapeutic use     ( E931.5 )

• 19  Anthelmintics causing adverse effects in therapeutic use     ( E931.6 )

• 20  Antiviral drugs causing adverse effects in therapeutic use     ( E931.7 )

• 21  Other antimycobacterial drugs causing adverse effects in therapeutic use     ( E931.8 )

• 22  Other and unspecified anti-infectives causing adverse effects in therapeutic use     ( E931.9 )

• 23  Hormones and synthetic substitutes causing adverse effects in therapeutic use     ( E932 )

• 24  Adrenal cortical steroids causing adverse effects in therapeutic use     ( E932.0 )

• 25  Androgens and anabolic congeners causing adverse effects in therapeutic use     ( E932.1 )

• 26  Ovarian hormones and synthetic substitutes causing adverse effects in therapeutic use     ( E932.2 )

• 27  Insulins and antidiabetic agents causing adverse effects in therapeutic use     ( E932.3 )

• 28  Anterior pituitary hormones causing adverse effects in therapeutic use     ( E932.4 )

• 29  Posterior pituitary hormones causing adverse effects in therapeutic use     ( E932.5 )

• 30  Parathyroid and parathyroid derivatives causing adverse effects in therapeutic use     ( E932.6 )

• 31  Thyroid and thyroid derivatives causing adverse effects in therapeutic use     ( E932.7 )

• 32  Antithyroid agents causing adverse effects in therapeutic use     ( E932.8 )

• 33  Other and unspecified hormones and synthetic substitutes causing adverse effects in therapeutic use     ( E932.9 )

• 34  Primarily systemic agents causing adverse effects in therapeutic use     ( E933 )

• 35  Antiallergic and antiemetic drugs causing adverse effects in therapeutic use     ( E933.0 )

• 36  Antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use     ( E933.1 )

• 37  Acidifying agents causing adverse effects in therapeutic use     ( E933.2 )

• 38  Alkalizing agents causing adverse effects in therapeutic use     ( E933.3 )

• 39  Enzymes not elsewhere classified causing adverse effects in therapeutic use     ( E933.4 )

• 40  Vitamins not elsewhere classified causing adverse effects in therapeutic use     ( E933.5 )

• 41  Adverse effect of oral biphosphates     ( E933.6 )

• 42  Adverse effect of intravenous biphosphates     ( E933.7 )

• 43  Other systemic agents not elsewhere classified causing adverse effects in therapeutic use     ( E933.8 )

• 44  Unspecified systemic agent causing adverse effects in therapeutic use     ( E933.9 )

• 45  Agents primarily affecting blood constituents causing adverse effects in therapeutic use     ( E934 )

• 46  Iron and its compounds causing adverse effects in therapeutic use     ( E934.0 )

• 47  Liver preparations and other antianemic agents causing adverse effects in therapeutic use     ( E934.1 )

• 48  Anticoagulants causing adverse effects in therapeutic use     ( E934.2 )

• 49  Vitamin k (phytonadione) causing adverse effects in therapeutic use     ( E934.3 )

• 50  Fibrinolysis-affecting drugs causing adverse effects in therapeutic use     ( E934.4 )

• 51  Anticoagulant antagonists and other coagulants causing adverse effects in therapeutic use     ( E934.5 )

• 52  Gamma globulin causing adverse effects in therapeutic use     ( E934.6 )

• 53  Natural blood and blood products causing adverse effects in therapeutic use     ( E934.7 )

• 54  Other agents affecting blood constituents causing adverse effects in therapeutic use     ( E934.8 )

• 55  Unspecified agent affecting blood constituents causing adverse effects in therapeutic use     ( E934.9 )

• 56  Analgesics antipyretics and antirheumatics causing adverse effects in therapeutic use     ( E935 )

• 57  Heroin causing adverse effects in therapeutic use     ( E935.0 )

• 58  Methadone causing averse effects in therapeutic use     ( E935.1 )

• 59  Other opiates and related narcotics causing adverse effects in therapeutic use     ( E935.2 )

• 60  Salicylates causing adverse effects in therapeutic use     ( E935.3 )

• 61  Aromatic analgesics not elsewhere classified causing adverse effects in therapeutic use     ( E935.4 )

• 62  Pyrazole derivatives causing adverse effects in therapeutic use     ( E935.5 )

• 63  Antirheumatics (antiphlogistics) causing adverse effects in therapeutic use     ( E935.6 )

• 64  Other non-narcotic analgesics causing adverse effects in therapeutic use     ( E935.7 )

• 65  Other specified analgesics and antipyretics causing adverse effects in therapeutic use     ( E935.8 )

• 66  Unspecified analgesic and antipyretic causing adverse effects in therapeutic use     ( E935.9 )

• 67  Anticonvulsants and anti-parkinsonism drugs causing adverse effects in therapeutic use     ( E936 )

• 68  Oxazolidine derivatives causing adverse effects in therapeutic use     ( E936.0 )

• 69  Hydantoin derivatives causing adverse effects in therapeutic use     ( E936.1 )

• 70  Succinimides causing adverse effects in therapeutic use     ( E936.2 )

• 71  Other and unspecified anticonvulsants causing adverse effects in therapeutic use     ( E936.3 )

• 72  Anti-parkinsonism drugs causing adverse effects in therapeutic use     ( E936.4 )

• 73  Sedatives and hypnotics causing adverse effects in therapeutic use     ( E937 )

• 74  Barbiturates causing adverse effects in therapeutic use     ( E937.0 )

• 75  Chloral hydrate group causing adverse effects in therapeutic use     ( E937.1 )

• 76  Paraldehyde causing adverse effects in therapeutic use     ( E937.2 )

• 77  Bromine compounds causing adverse effects in therapeutic use     ( E937.3 )

• 78  Methaqualone compounds causing adverse effects in therapeutic use     ( E937.4 )

• 79  Glutethimide group causing adverse effects in therapeutic use     ( E937.5 )

• 80  Mixed sedatives not elsewhere classified causing adverse effects in therapeutic use     ( E937.6 )

• 81  Other sedatives and hypnotics causing adverse effects in therapeutic use     ( E937.8 )

• 82  Unspecified sedatives and hypnotics causing adverse effects in therapeutic use     ( E937.9 )

• 83  Other central nervous system depressants and anesthetics causing adverse effects in therapeutic use     ( E938 )

• 84  Central nervous system muscle-tone depressants causing adverse effects in therapeutic use     ( E938.0 )

• 85  Halothane causing adverse effects in therapeutic use     ( E938.1 )

• 86  Other gaseous anesthetics causing adverse effects in therapeutic use     ( E938.2 )

• 87  Intravenous anesthetics causing adverse effects in therapeutic use     ( E938.3 )

• 88  Other and unspecified general anesthetics causing adverse effects in therapeutic use     ( E938.4 )

• 89  Surface and infiltration anesthetics causing adverse effects in therapeutic use     ( E938.5 )

• 90  Peripheral nerve- and plexus-blocking anesthetics causing adverse effects in therapeutic use     ( E938.6 )

• 91  Spinal anesthetics causing adverse effects in therapeutic use     ( E938.7 )

• 92  Other and unspecified local anesthetics causing adverse effects in therapeutic use     ( E938.9 )

• 93  Psychotropic agents causing adverse effects in therapeutic use     ( E939 )

• 94  Antidepressants causing adverse effects in therapeutic use     ( E939.0 )

• 95  Phenothiazine-based tranquilizers causing adverse effects in therapeutic use     ( E939.1 )

• 96  Butyrophenone-based tranquilizers causing adverse effects in therapeutic use     ( E939.2 )

• 97  Other antipsychotics neuroleptics and major tranquilizers causing adverse effects in therapeutic use     ( E939.3 )

• 98  Benzodiazepine-based tranquilizers causing adverse effects in therapeutic use     ( E939.4 )

• 99  Other tranquilizers causing adverse effects in therapeutic use     ( E939.5 )

• 100  Psychodysleptics (hallucinogens) causing adverse effects in therapeutic use     ( E939.6 )

• 101  Psychostimulants causing adverse effects in therapeutic use     ( E939.7 )

• 102  Other psychotropic agents causing adverse effects in therapeutic use     ( E939.8 )

• 103  Unspecified psychotropic agent causing adverse effects in therapeutic use     ( E939.9 )

• 104  Central nervous system stimulants causing adverse effects in therapeutic use     ( E940 )

• 105  Analeptics causing adverse effects in therapeutic use     ( E940.0 )

• 106  Opiate antagonists causing adverse effects in therapeutic use     ( E940.1 )

• 107  Other specified central nervous system stimulants causing adverse effects in therapeutic use     ( E940.8 )

• 108  Unspecified central nervous system stimulant causing adverse effects in therapeutic use     ( E940.9 )

• 109  Drugs primarily affecting the autonomic nervous system causing adverse effects in therapeutic use     ( E941 )

• 110  Parasympathomimetics (cholinergics) causing adverse effects in therapeutic use     ( E941.0 )

• 111  Parasympatholytics (anticholinergics and antimuscarinics) and spasmolytics causing adverse effects in therapeutic use     ( E941.1 )

• 112  Sympathomimetics (adrenergics) causing adverse effects in therapeutic use     ( E941.2 )

• 113  Sympatholytics (antiadrenergics) causing adverse effects in therapeutic use     ( E941.3 )

• 114  Unspecified drug primarily affecting the autonomic nervous system causing adverse effects in therapeutic use     ( E941.9 )

• 115  Agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use     ( E942 )

• 116  Cardiac rhythm regulators causing adverse effects in therapeutic use     ( E942.0 )

• 117  Cardiotonic glycosides and drugs of similar action causing adverse effects in therapeutic use     ( E942.1 )

• 118  Antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use     ( E942.2 )

• 119  Ganglion-blocking agents causing adverse effects in therapeutic use     ( E942.3 )

• 120  Coronary vasodilators causing adverse effects in therapeutic use     ( E942.4 )

• 121  Other vasodilators causing adverse effects in therapeutic use     ( E942.5 )

• 122  Other antihypertensive agents causing adverse effects in therapeutic use     ( E942.6 )

• 123  Antivaricose drugs including sclerosing agents causing adverse effects in therapeutic use     ( E942.7 )

• 124  Capillary-active drugs causing adverse effects in therapeutic use     ( E942.8 )

• 125  Other and unspecified agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use     ( E942.9 )

• 126  Agents primarily affecting gastrointestinal system causing adverse effects in therapeutic use     ( E943 )

• 127  Antacids and antigastric secretion drugs causing adverse effects in therapeutic use     ( E943.0 )

• 128  Irritant cathartics causing adverse effects in therapeutic use     ( E943.1 )

• 129  Emollient cathartics causing adverse effects in therapeutic use     ( E943.2 )

• 130  Other cathartics including intestinal atonia drugs causing adverse effects in therapeutic use     ( E943.3 )

• 131  Digestants causing adverse effects in therapeutic use     ( E943.4 )

• 132  Antidiarrheal drugs causing adverse effects in therapeutic use     ( E943.5 )

• 133  Emetics causing adverse effects in therapeutic use     ( E943.6 )

• 134  Other specified agents primarily affecting the gastro-intestinal system causing adverse effects in therapeutic use     ( E943.8 )

• 135  Unspecified agent primarily affecting the gastrointestinal system causing adverse effects in therapeutic use     ( E943.9 )

• 136  Water mineral and uric acid metabolism drugs causing adverse effects in therapeutic use     ( E944 )

• 137  Mercurial diuretics causing adverse effects in therapeutic use     ( E944.0 )

• 138  Purine derivative diuretics causing adverse effects in therapeutic use     ( E944.1 )

• 139  Carbonic acid anhydrase inhibitors causing adverse effects in therapeutic use     ( E944.2 )

• 140  Saluretics causing adverse effects in therapeutic use     ( E944.3 )

• 141  Other diuretics causing adverse effects in therapeutic use     ( E944.4 )

• 142  Electolytic caloric and water-balance agents causing adverse effects in therapeutic use     ( E944.5 )

• 143  Other mineral salts not elsewhere classified causing adverse effects in therapeutic use     ( E944.6 )

• 144  Uric acid metabolism drugs causing adverse effects in therapeutic use     ( E944.7 )

• 145  Agents primarily acting on the smooth and skeletal muscles and respiratory system causing adverse effects in therapeutic use     ( E945 )

• 146  Oxytocic agents causing adverse effects in therapeutic use     ( E945.0 )

• 147  Smooth muscle relaxants causing adverse effects in therapeutic use     ( E945.1 )

• 148  Skeletal muscle relaxants causing adverse effects in therapeutic use     ( E945.2 )

• 149  Other and unspecified drugs acting on muscles causing adverse effects in therapeutic use     ( E945.3 )

• 150  Antitussives causing adverse effects in therapeutic use     ( E945.4 )

• 151  Expectorants causing adverse effects in therapeutic use     ( E945.5 )

• 152  Anti-common cold drugs causing adverse effects in therapeutic use     ( E945.6 )

• 153  Antiasthmatics causing adverse effects in therapeutic use     ( E945.7 )

• 154  Other and unspecified respiratory drugs causing adverse effects in therapeutic use     ( E945.8 )

• 155  Agents primarily affecting skin and mucous membrane ophthalmo logical otorhinolaryngological and dental drugs causing adverse effects in therapeutic use     ( E946 )

• 156  Local anti-infectives and anti-inflammatory drugs causing adverse effects in therapeutic use     ( E946.0 )

• 157  Antipruritics causing adverse effects in therapeutic use     ( E946.1 )

• 158  Local astringents and local detergents causing adverse effects in therapeutic use     ( E946.2 )

• 159  Emollients demulcents and protectants causing adverse effects in therapeutic use     ( E946.3 )

• 160  Keratolytics keratoplastics other hair treatment drugs and preparations causing adverse effects in therapeutic use     ( E946.4 )

• 161  Eye anti-infectives and other eye drugs causing adverse effects in therapeutic use     ( E946.5 )

• 162  Anti-infectives and other drugs and preparations for ear nose and throat causing adverse effects in therapeutic use     ( E946.6 )

• 163  Dental drugs topically applied causing adverse effects in therapeutic use     ( E946.7 )

• 164  Other agents primarily affecting skin and mucous membrane causing adverse effects in therapeutic use     ( E946.8 )

• 165  Unspecified agent primarily affecting skin and mucous membrane causing adverse effects in therapeutic use     ( E946.9 )

• 166  Other and unspecified drugs and medicinal substances causing adverse effects in therapeutic use     ( E947 )

• 167  Dietetics causing adverse effects in therapeutic use     ( E947.0 )

• 168  Lipotropic drugs causing adverse effects in therapeutic use     ( E947.1 )

• 169  Antidotes and chelating agents not elsewhere classified causing adverse effects in therapeutic use     ( E947.2 )

• 170  Alcohol deterrents causing adverse effects in therapeutic use     ( E947.3 )

• 171  Pharmaceutical excipients causing adverse effects in therapeutic use     ( E947.4 )

• 172  Other drugs and medicinal substances causing adverse effects in therapeutic use     ( E947.8 )

• 173  Unspecified drug or medicinal substance causing adverse effects in therapeutic use     ( E947.9 )

• 174  Bacterial vaccines causing adverse effects in therapeutic use     ( E948 )

• 175   BCG vaccine causing adverse effects in therapeutic use     ( E948.0 )

• 176  Typhoid and paratyphoid vaccines causing adverse effects in therapeutic use     ( E948.1 )

• 177  Cholera vaccine causing adverse effects in therapeutic use     ( E948.2 )

• 178  Plague vaccine causing adverse effects in therapeutic use     ( E948.3 )

• 179  Tetanus vaccine causing adverse effects in therapeutic use     ( E948.4 )

• 180  Diphtheria vaccine causing adverse effects in therapeutic use     ( E948.5 )

• 181  Pertussis vaccine including combinations with a pertussis component causing adverse effects in therapeutic use     ( E948.6 )

• 182  Other and unspecified bacterial vaccines causing adverse effects in therapeutic use     ( E948.8 )

• 183  Mixed bacterial vaccines except combinations with a pertussis component causing adverse effects in therapeutic use     ( E948.9 )

• 184  Other vaccines and biological substances causing adverse effects in therapeutic use     ( E949 )

• 185  Smallpox vaccine causing adverse effects in therapeutic use     ( E949.0 )

• 186  Rabies vaccine causing adverse effects in therapeutic use     ( E949.1 )

• 187  Typhus vaccine causing adverse effects in therapeutic use     ( E949.2 )

• 188  Yellow fever vaccine causing adverse effects in therapeutic use     ( E949.3 )

• 189  Measles vaccine causing adverse effects in therapeutic use     ( E949.4 )

• 190  Poliomyelitis vaccine causing adverse effects in therapeutic use     ( E949.5 )

• 191  Other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use     ( E949.6 )

• 192  Mixed viral-rickettsial and bacterial vaccines except combinations with a pertussis component causing adverse effects in therapeutic use     ( E949.7 )

• 193  Other and unspecified vaccines and biological substances causing adverse effects in therapeutic use     ( E949.9 )